Non-Interventional Report on Parameters of Acceptability, Efficacy and Compliance of Fulvestrant in Post-Menopausal Patients With Advanced Breast Cancer HR Positive Who Progresses to One Prior Endocrine Therapy With Antiestrogens.
Phase of Trial: Phase IV
Latest Information Update: 04 Jan 2011
At a glance
- Drugs Fulvestrant (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms FRAME
- Sponsors AstraZeneca
- 04 Jan 2011 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 04 Jan 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2010 Planned End Date changed from 1 Feb 2011 to 1 Oct 2011 as reported by ClinicalTrials.gov.